Trial Profile
Clinical Trials Insight: 700007526
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 26 Mar 2024
Price :
$35
*
At a glance
- Drugs Ragweed allergy immunotherapy 1018-ISS conjugate (Primary)
- Indications Allergic asthma; Seasonal allergic rhinitis
- Focus Therapeutic Use
- 10 Nov 2005 New trial record.